Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy - Poll - MDSpire

Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

  • By

  • Todd Hulgan

  • Kristine M Erlandson

  • Yuki Bradford

  • Katherine Tassiopoulos

  • Kunling Wu

  • Sara H Bares

  • Todd T Brown

  • Jordan E Lake

  • Michael Leonard

  • Grace A McComsey

  • Marylyn D Ritchie

  • Paul E Sax

  • John R Koethe

  • David W Haas

  • November 28, 2025

  • 0 min

Share

Original Source(s)

Melanocortin-4 Receptor Gene Variants and Weight Change Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy

  • by Todd Hulgan, Kristine M Erlandson, Yuki Bradford, Katherine Tassiopoulos, Kunling Wu, Sara H Bares, Todd T Brown, Jordan E Lake, Michael Leonard, Grace A McComsey, Marylyn D Ritchie, Paul E Sax, John R Koethe, David W Haas

  • November 28, 2025

Related Content

The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction

Visceral fat area and blood lipids in colorectal cancer: predictors of surgical risk and prognosis

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.